Navigation Links
Biodel to Present Data from Product Development Programs at 2010 Diabetes Technology Meeting
Date:11/8/2010

DANBURY, Conn., Nov. 8, 2010 /PRNewswire/ --  Biodel Inc. (Nasdaq: BIOD) announced today that the following abstracts describing recent findings from the company's product development programs have been accepted for poster presentation at the Tenth Annual Diabetes Technology Meeting in Bethesda, MD, November 11 and 12, 2010:

"Characterization of Pharmacokinetics and Toleration of Three Variant Formulations of Linjeta"; presented by Dr. Frank Flacke, November 12

"A Stabilized Liquid Glucagon Formulation For Bi-hormonal Pump Use"; presented by Dr. Solomon Steiner, November 12

"A New Formulation of Insulin Glargine with an Extended Release Profile"; presented by Dr. Roderike Pohl, November 12

"'Smart' Basal Insulin Formulation That Releases Insulin in Response to Changing Blood Glucose Concentrations"; presented by Nandini Kashyap, November 11

The posters will be available on the company's website, www.biodel.com.  

The Diabetes Technology Meeting focuses on the latest technological advances for people with diabetes.  Its purpose is to bring together technology developers and users to facilitate the creation of new and cost-effective tools—including an artificial pancreas—to help people with diabetes.   This year's meeting will include sessions on technologies for metabolic monitoring, biomarkers for early diagnosis of diabetes, the performance of closed-loop artificial pancreas systems and alternative delivery routes for insulin.

About Biodel Inc.

Biodel Inc. is a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for diabetes.  Biodel's product candidates are developed using VIAdel™ technology, which reformulates existing FDA-approved peptide drugs.  Linjeta™ is Biodel's most ad
'/>"/>

SOURCE Biodel Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Biodel Awarded $1.2 Million in Therapeutic Discovery Research Grants From IRS
2. FDA Issues Complete Response Letter to Biodel Regarding New Drug Application for Linjeta™
3. Biodel to Present at Upcoming Conferences
4. Biodel Reports Research Progress in Poster Session on Short-Acting Insulins at 46th EASD Annual Meeting
5. Biodel Appoints Arthur Urciuoli to its Board of Directors
6. Biodel to Raise $9.4 Million Through Registered Direct Offering
7. Biodel Announces Schedule for Presentations at the 37th Annual Meeting and Exposition of the Controlled Release Society
8. Biodel Inc. Announces the Completion of Its Two Pivotal Trials and the Release of EASD Abstracts Containing Additional Interim Data From Its VIAject(TM) Program
9. Biodel Inc. Completes Enrollment of Two Pivotal Phase III Clinical Trials of VIAject(TM) and Plans Manufacturing Facility for VIAject(TM)
10. Biodel Inc. Expands Ongoing Phase III VIAject(TM) Clinical Trials Into Europe
11. Varian Medical Systems Management to Present at Lazard Capital Markets 7th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... PLYMOUTH MEETING, Pa. , Aug. 28, 2014 ... surgical community, patients, and media, both for the ... to patient safety. The quick deployment of surgical ... new technology are prompting facilities to evaluate their ... for the entire surgical team.    ...
(Date:8/28/2014)... 2014 Amgen (NASDAQ: AMGN ) ... (BLA) to the U.S. Food and Drug Administration (FDA) ... cholesterol. Evolocumab is an investigational fully human monoclonal antibody ... protein that reduces the liver,s ability to remove low-density ... 1 ­ The BLA ...
(Date:8/28/2014)... ALISO VIEJO , Kalifornien, 28. ... Inc., hat heute den Start der ... Investigational Device Exemption, Forschungsausnahmegenehmigung) zur Beurteilung ... Systems zur Embolisation von Aneurysmen („WEB") ... University of Tennessee, Department of Neurosurgery/Semmes-Murphey ...
Breaking Medicine Technology:Surgical Robot Risk and Safety: ECRI Institute and Hartford Hospital Launch New Education Series 2Surgical Robot Risk and Safety: ECRI Institute and Hartford Hospital Launch New Education Series 3Surgical Robot Risk and Safety: ECRI Institute and Hartford Hospital Launch New Education Series 4Surgical Robot Risk and Safety: ECRI Institute and Hartford Hospital Launch New Education Series 5Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA 2Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA 3Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA 4Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA 5Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA 6Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA 7Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA 8Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA 9Sequent Medical kündigt Start einer IDE-Studie für das WEB System zur Embolisation von Aneurysmen bekannt 2Sequent Medical kündigt Start einer IDE-Studie für das WEB System zur Embolisation von Aneurysmen bekannt 3
(Date:8/28/2014)... vaccine to prevent Ebola virus disease will begin next ... Diseases (NIAID), part of the National Institutes of Health. ... of a vaccine co-developed by NIAID and GlaxoSmithKline (GSK) ... to generate an immune system response in healthy adults. ... in Bethesda, Maryland. , The study is the first ...
(Date:8/28/2014)... 70 and over who identify themselves as ,old, feel ... perceive they have lower value than younger age groups. ... Kent, titled ,Being old and ill, across different countries: ... used data from the European Social Survey. Respondents, who ... self-rate their health., The researchers found that those living ...
(Date:8/28/2014)... August 28, 2014 Vaccine market - ... great interest among other healthcare industry sectors and sub-circles ... demand in vaccine with respect to evolving and spreading ... due to an improved understanding for a well-balanced life ... States. It has led to new opportunities for manufacturing ...
(Date:8/28/2014)... TX (PRWEB) August 28, 2014 After ... Dr. Paul Vitenas is excited to announce the ... of its kind in any city, Mirror Mirror Beauty ... building. , Situated on the corner of Richmond and ... modern architecture, luxurious amenities, and cutting-edge technology in a ...
(Date:8/28/2014)... Steven Reinberg HealthDay ... Treating pre-cancerous skin spots with a type of light therapy ... the lesions with liquid nitrogen, a new study suggests. ... the scalp and face of people with fair complexions who,ve ... of prior research found that people who underwent the light ...
Breaking Medicine News(10 mins):Health News:NIH to Launch human safety study of Ebola vaccine candidate 2Health News:NIH to Launch human safety study of Ebola vaccine candidate 3Health News:NIH to Launch human safety study of Ebola vaccine candidate 4Health News:NIH to Launch human safety study of Ebola vaccine candidate 5Health News:U.S. Vaccine Market: Opportunities and Threats by Transparency Market Research 2Health News:U.S. Vaccine Market: Opportunities and Threats by Transparency Market Research 3Health News:Mirror Mirror Beauty Boutique to Welcome Its First Patients 2Health News: Light Therapy a Good Option for Pre-Cancerous Skin Lesions, Study Says 2Health News: Light Therapy a Good Option for Pre-Cancerous Skin Lesions, Study Says 3
... ... Hearing Institute (BHI) is urging families across America to make 2010 the year ... in response to new data that underscores the influence family members have in ... of nearly 47,000 households, more than half (51%) of new first-time owners of ...
... ... home top honors in American Spa Magazine,s 2009 Professional,s Choice Award in the Favorite ... ... 8, 2009 -- Oakworks® Inc., the premier U.S. manufacturer of wellness, spa, massage and ...
... , PHOENIX, Dec. 7 To standing cheers, ... (NNU) today unanimously endorsed the creation of the largest union ... and projected a major escalation in campaigns to expand union ... , "The promise of the future has arrived," said Karen ...
... Calif., Dec. 7 Patriot Scientific Corporation (OTC Bulletin ... its Board of Directors and will serve as chair ... 16 years of experience working in the software development ... and the delivery of consulting services for Cognizant Technology ...
... , LOS ANGELES, Dec. 7 Steeped in ... on Crystal Cruises, April 26 "Mind, Body and Spirit" ... the spiritual heritage of the region via personal meetings with ... meditation center, while guest health experts share insights on life ...
... , Department of Health Reminds At-Risk Pennsylvanians to ... federal Centers for Disease Control and Prevention, or CDC, ... flu vaccine to Pennsylvania to date, the state Department ... been distributed to 1,639 certified providers including pediatricians, family ...
Cached Medicine News:Health News:Study Finds Family Members Play Critical Role in Addressing Loved Ones' Hearing Loss 2Health News:Study Finds Family Members Play Critical Role in Addressing Loved Ones' Hearing Loss 3Health News:Study Finds Family Members Play Critical Role in Addressing Loved Ones' Hearing Loss 4Health News:Wellness Manufacturer Wins Two 2009 American Spa Awards 2Health News:Unanimous Vote Creates Largest RN Union in U.S. History 2Health News:Patriot Scientific Corporation Announces New Director 2Health News:Wellness Cruise Offers Crystal Guests 'Indian Ocean Insight' 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: